T2DM may also contribute to skeletal muscle degradation through extracellular matrix (ECM) remodeling, which disrupts insulin signaling and promotes muscle fibrosis and dysfunction, thereby accelerating sarcopenia progression (13). Here, INS is linked to type 2 diabetes mellitus.